Breaking News
Here is what we know: U.S. taxpayer money, funneled through USAID and NIH,...
Empire at 250: Can the Principles of 1776 Survive the American Police State?
The Public Choice Problem of AI Rights
Greenspan Was The Perfect Fed Chair. That Is Not a Compliment
Top Tech News
Speculations on What Could Show Physics Beyond the Standard Model
SpaceX Orbital Travel and Orbital Hotels Need Starfall – Getting Back Safe and Cheap is Exciting
Lizard-inspired wiggly wheels let Mars rover swim through sand
Fact Sheet: President Donald J. Trump Ushers in the Next Frontier of Quantum Innovation
Researchers at Johns Hopkins University just let an AI-guided robot remove a dead pig's gallblad
World's first consumer wing-in-ground effect aircraft takes flight
America's Military Readiness Depends On Deployable Nuclear Power
License Plate Cameras Are About To Start Tracking A Lot More Than Just Your Car
Heads up: Apparently the government is hiding cameras inside fake utility boxes
Sodium Batteries And EVs That Power The Grid: Inside GM's Big Energy Push
Expert Guts Claims That HPV Vaccine Reduces Cancer Risk
In an interview on the "Slobodni Podcast," Tomljenovi? said safety and efficacy claims are unsubstantiated, and the benefits of the vaccine do not outweigh the risks.
Public health policy should rest on solid, transparent evidence — not slogans, not marketing and not selective readings of scientific reviews, biochemist Lucija Tomljenovi?, Ph.D., said recently.
In a wide-ranging interview on the "Slobodni Podcast," Tomljenovi? challenged the evidence base for HPV vaccination programs.
She told host Andrija Klari? that safety and efficacy claims are unsubstantiated, and the benefits of the vaccine do not outweigh the risks.
The widely circulated claim that the HPV vaccine dramatically reduces cervical cancer risk — by as much as 80% if administered before age 16 — collapses under closer examination.
Tomljenovi? has published more than a dozen papers on the HPV vaccine. She was also an expert witness in litigation against Merck, maker of the Gardasil HPV vaccine. In that role, she presented a systematic critique of the claims that the HPV vaccine prevents cancer.
She also delivered an overview of the science on the adverse events associated with the shot, and she presented evidence that Merck manipulated regulators and legislators to grow the market for its vaccine.
Claims that HPV vaccine reduces cancer risk based on flawed Cochrane reviews
Tomljenovi? explained for "Slobodni" listeners why the 2025 Cochrane reviews on HPV vaccines — widely cited by health authorities and the media to support the claim that the vaccine reduces cervical cancer incidence by up to 80% — are flawed.
She said the reviews' own data undermine their conclusions.
The Cochrane Library is often regarded as the gold standard of systematic reviews, she said. Mainstream health institutions often base recommendations on findings from Cochrane.
However, systematic reviews are only as reliable as the studies they include, she said.
According to Tomljenovi?'s analysis of the 300-plus-page review, the majority of epidemiological studies cited to show the vaccine's effects — including its ability to stop invasive cervical cancer — had serious or critical risk of bias, according to the ratings of Cochrane's own reviewers.